Implications of gliotransmission for the pharmacotherapy of CNS disorders

CNS Drugs

Volumn 25, Issue 8, 2011, Pages 641-658

  Rossi, Daniela ^a   Martorana, Francesca ^a   Brambilla, Liliana ^a  

^a IRCCS   (Italy)

Author keywords

Acquired immunodeficiency syndrome; Alzheimers disease; Cerebral ischaemia; CNS disorders; Cyclo oxygenase 2 inhibitors; Dementia; Etanercept; Memantine; NMDA receptor antagonists; Tumour necrosis factor inhibitors.

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CELECOXIB; CHEMOKINE RECEPTOR CXCR4; CYCLOOXYGENASE 2 INHIBITOR; DEXTRO SERINE; ETANERCEPT; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; GLYCOPROTEIN GP 120; IBUPROFEN; ICOSANOID; INFLIXIMAB; MEMANTINE; METABOTROPIC RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER RECEPTOR; NITRIC OXIDE; NORADRENALIN; PHOSPHOLIPASE A2; PROSTAGLANDIN SYNTHASE; PROTEINASE ACTIVATED RECEPTOR 1; PURINERGIC P2Y1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; VIRUS PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL BEHAVIOR; ANKYLOSING SPONDYLITIS; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN MICROCIRCULATION; BRAIN TISSUE; BREATHING; CALCIUM SIGNALING; CELL ACTIVATION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; DRUG SAFETY; DRUG TOLERABILITY; ENDOPLASMIC RETICULUM; EXCITOTOXICITY; EXOCYTOSIS; GLIOTRANSMISSION; GRAY MATTER; HIPPOCAMPUS; HIV ASSOCIATED DEMENTIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; MACROPHAGE; METABOLISM; MICROGLIA; MOLECULAR INTERACTION; NERVE CELL INHIBITION; NERVE EXCITABILITY; NEUROLOGIC DISEASE; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NITROSYLATION; NONHUMAN; OSCILLATION; PARENCHYMA; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SLEEP; SMOOTH MUSCLE FIBER; SYNAPSE; SYNAPTIC TRANSMISSION; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; DRUG DELIVERY SYSTEMS; GLUTAMIC ACID; HUMANS; NEURODEGENERATIVE DISEASES; NEUROGLIA; SIGNAL TRANSDUCTION;

EID: 79960784675     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.2165/11593090-000000000-00000     Document Type: Article

References (195)

1. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005; 6 (8): 626-40 (Pubitemid 41059337)
2. Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci 2009; 32 (8): 421-31
3. Halassa MM, Haydon PG. Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior. Annu Rev Physiol 2010; 72: 335-55
4. Virchow R. Die Cellularpathologie in ihrer Begrü ndung auf physiologische und pathologische Gewebelehre. Zwanzig Vorlesungen gehalten wä hrend der Monate Februar, Mä rz und April 1858 im pathologischen Institut zu Berlin. 1st ed. Berlin: A. Hirschwald, 1858
5. KettenmannH,RansomBR. In:Neuroglia.KettenmannH, Ransom BR, editors. 2nd ed. Oxford: Oxford University Press, 2005
6. Kettenmann H, Verkhratsky A. Neuroglia: the 150 years after. Trends Neurosci 2008; 31 (12): 653-9
7. Tower DB, Young OM. The activities of butyrylcholinesterase and carbonic anhydrase, the rate of anaerobic glycolysis, and the question of a constant density of glial cells in cerebral cortices of various mammalian species from mouse to whale. J Neurochem 1973; 20 (2): 269-78
8. Heneka MT, Rodriguez JJ, Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev 2010; 63 (1-2): 189-211
9. Hansson E, Ronnback L. Glial neuronal signalling in the central nervous system. FASEB J 2003; 17 (3): 341-8 (Pubitemid 36292950)
10. Jourdain P, Bergersen LH, Bhaukaurally K, et al. Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci 2007; 10 (3): 331-9
11. Navarrete M, Araque A. Endocannabinoids mediate neuron-astrocyte communication. Neuron 2008; 57 (6): 883-93 (Pubitemid 351400634)
12. Henneberger C, Papouin T, Oliet SH, et al. Long-term potentiation depends on release of D-serine from astrocytes. Nature 2010; 463 (7278): 232-6
13. Suzuki A, Stern SA, Bozdagi O, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 2011; 144 (5): 810-23
14. Santello M, Bezzi P, Volterra A. TNFalpha controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 2011; 69 (5): 988-1001
15. Halassa MM, Florian C, Fellin T, et al. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009; 61 (2): 213-9
16. Gourine AV, Kasymov V, Marina N, et al. Astrocytes control breathing through pH-dependent release of ATP. Science 2010; 329 (5991): 571-5
17. HuxtableAG, Zwicker JD,Alvares TS, et al. Glia contribute to the purinergic modulation of inspiratory rhythmgenerating networks. J Neurosci 2010; 30 (11): 3947-58
18. Giaume C, Koulakoff A, Roux L, et al. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 2010; 11 (2): 87-99
19. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65 (1): 1-105 (Pubitemid 32479155)
20. Kofuji P, Newman EA. Potassium buffering in the central nervous system. Neuroscience 2004; 129 (4): 1045-56 (Pubitemid 39556255)
21. Simard M, Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004; 129 (4): 877-96 (Pubitemid 39556241)
22. Giaume C, Kirchhoff F, Matute C, et al. Glia: the fulcrum of brain diseases. Cell Death Differ 2007; 14 (7): 1324-35 (Pubitemid 46965262)
23. Verkhratsky A, Parpura V. Recent advances in (patho)-physiology of astroglia. Acta Pharmacol Sin 2010; 31 (9): 1044-54
24. Verkhratsky A, Orkand RK, Kettenmann H. Glial calcium: homeostasis and signalling function. Physiol Rev 1998; 78 (1): 99-141 (Pubitemid 28070976)
25. Volterra A, Magistretti PJ, Haydon PG, editors. The tripartite synapse: glia in synaptic transmission. Oxford, UK: Oxford University Press, 2002
26. Miller RH, Raff MC. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurosci 1984; 4 (2): 585-92 (Pubitemid 14125393)
27. Bushong EA, Martone ME, Jones YZ, et al. Protoplasmic astrocytes in CA1 stratum radiatum occupy separate anatomical domains. J Neurosci 2002; 22 (1): 183-92 (Pubitemid 34033496)
28. Bushong EA, Martone ME, Ellisman MH. Maturation of astrocyte morphology and the establishment of astrocyte domains during postnatal hippocampal development. Int J Dev Neurosci 2004; 22 (2): 73-86 (Pubitemid 38264165)
29. Halassa MM, Fellin T, Takano H, et al. Synaptic islands defined by the territory of a single astrocyte. J Neurosci 2007; 27 (24): 6473-7 (Pubitemid 46920364)
30. Nedergaard M, Rodriguez JJ, Verkhratsky A. Glial calcium and diseases of the nervous system. Cell Calcium 2010; 47 (2): 140-9
31. Charles AC, Merrill JE, Dirksen ER, et al. Intercellular signalling in glial cells: calcium waves and oscillations in response to mechanical stimulation and glutamate. Neuron 1991; 6 (6): 983-92
32. Cornell-Bell AH, Finkbeiner SM, Cooper MS, et al. Glutamate induces calcium waves in cultured astrocytes: longrange glial signalling. Science 1990; 247 (4941): 470-3
33. Aguado F, Espinosa-Parrilla JF, Carmona MA, et al. Neuronal activity regulates correlated network properties of spontaneous calcium transients in astrocytes in situ. J Neurosci 2002; 22 (21): 9430-44 (Pubitemid 35356186)
34. Hirase H, Qian L, Barthó P, et al. Calcium dynamics of cortical astrocytic networks in vivo. PLoS Biol 2004; 2 (4): E96
35. Nett WJ, Oloff SH, McCarthy KD. Hippocampal astrocytes in situ exhibit calcium oscillations that occur independent of neuronal activity. J Neurophysiol 2002; 87 (1): 528-37 (Pubitemid 34669968)
36. Nimmerjahn A, Kirchhoff F, Kerr JN, et al. Sulforhodamine 101 as a specific marker of astroglia in the neocortex in vivo. Nat Methods 2004; 1 (1): 31-7
37. Parri HR, Gould TM, Crunelli V. Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation. Nat Neurosci 2001; 4 (8): 803-12 (Pubitemid 32702512)
38. Simard M, Arcuino G, Takano T, et al. Signalling at the gliovascular interface. J Neurosci 2003; 23 (27): 9254-62
39. Zonta M, Angulo MC, Gobbo S, et al. Neuron-to-astrocyte signalling is central to the dynamic control of brain microcirculation. Nat Neurosci 2003; 6 (1): 43-50 (Pubitemid 36026331)
40. Zonta M, Sebelin A, Gobbo S, et al. Glutamate-mediated cytosolic calcium oscillations regulate a pulsatile prostaglandin release from cultured rat astrocytes. J Physiol 2003; 553 (Pt 2): 407-14 (Pubitemid 37527544)
41. Mulligan SJ, MacVicar BA. Calcium transients in astrocyte endfeet cause cerebrovascular constrictions. Nature 2004; 431 (7005): 195-9 (Pubitemid 39243473)
42. Metea MR, Newman EA. Glial cells dilate and constrict blood vessels: a mechanism of neurovascular coupling. J Neurosci 2006; 26 (11): 2862-70
43. Takano T, Tian GF, Peng W, et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006; 9 (2): 260-7 (Pubitemid 43164550)
44. Gordon GR, Choi HB, Rungta RL, et al. Brain metabolism dictates the polarity of astrocyte control over arterioles. Nature 2008; 456 (7223): 745-9
45. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci 2007; 10 (11): 1369-76 (Pubitemid 350014688)
46. Gordon GR, Mulligan SJ, MacVicar BA. Astrocyte control of the cerebrovasculature. Glia 2007; 55 (12): 1214-21 (Pubitemid 47235363)
47. Carmignoto G, Gomez-Gonzalo M. The contribution of astrocyte signalling to neurovascular coupling. Brain Res Rev 2010; 63 (1-2): 138-48
48. Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature 2010; 468 (7321): 232-43
49. Pasti L, Volterra A, Pozzan T, et al. Intracellular calcium oscillations in astrocytes: a highly plastic, bidirectional form of communication between neurons and astrocytes in situ. J Neurosci 1997; 17 (20): 7817-30 (Pubitemid 27426219)
50. Angulo MC, Kozlov AS, Charpak S, et al. Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. J Neurosci 2004; 24 (31): 6920-7 (Pubitemid 39045449)
51. Fellin T, Pascual O, Gobbo S, et al. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004; 43 (5): 729-43 (Pubitemid 39179731)
52. Kozlov AS, Angulo MC, Audinat E, et al. Target cellspecific modulation of neuronal activity by astrocytes. Proc Natl Acad Sci USA 2006; 103 (26): 10058-63 (Pubitemid 43993622)
53. Lee CJ, Mannaioni G, Yuan H, et al. Astrocytic control of synaptic NMDA receptors. J Physiol 2007; 581 (Pt 3): 1057-81 (Pubitemid 46887980)
54. Perea G, Araque A. Astrocytes potentiate transmitter release at single hippocampal synapses. Science 2007; 317 (5841): 1083-6 (Pubitemid 47330192)
55. Shigetomi E, Bowser DN, Sofroniew MV, et al. Two forms of astrocyte calcium excitability have distinct effects on NMDA receptor-mediated slow inward currents in pyramidal neurons. J Neurosci 2008; 28 (26): 6659-63
56. Hamilton NB, Attwell D. Do astrocytes really exocytose neurotransmitters? Nat Rev Neurosci 2010; 11 (4): 227-38
57. Fiacco TA, Agulhon C, Taves SR, et al. Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron 2007; 54 (4): 611-26 (Pubitemid 46756143)
58. Agulhon C, Fiacco TA, McCarthy KD. Hippocampal short-and long-term plasticity are not modulated by astrocyte Ca2+ signalling. Science 2010; 327 (5970): 1250-4
59. Parpura V, Basarsky TA, Liu F, et al. Glutamate-mediated astrocyte-neuron signalling. Nature 1994; 369 (6483): 744-7 (Pubitemid 24225363)
60. Bezzi P, Carmignoto G, Pasti L, et al. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 1998; 391 (6664): 281-5 (Pubitemid 28099014)
61. Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000; 403 (6767): 316-21 (Pubitemid 30062388)
62. Duan S, Anderson CM, Keung EC, et al. P2X7 receptormediated release of excitatory amino acids from astrocytes. J Neurosci 2003; 23 (4): 1320-8 (Pubitemid 36258910)
63. Ye ZC, Wyeth MS, Baltan-Tekkok S, et al. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J Neurosci 2003; 23 (9): 3588-96 (Pubitemid 36958466)
64. Kang J, Kang N, Lovatt D, et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 2008; 28 (18): 4702-11
65. Kimelberg HK, Goderie SK, Higman S, et al. Swellinginduced release of glutamate, aspartate, and taurine from astrocyte cultures. J Neurosci 1990; 10 (5): 1583-91
66. Sanzgiri RP, Araque A, Haydon PG. Prostaglandin E(2) stimulates glutamate receptor-dependent astrocyte neuromodulation in cultured hippocampal cells. J Neurobiol 1999; 41 (2): 221-9 (Pubitemid 29494148)
67. Jeremic A, Jeftinija K, Stevanovic J, et al. ATP stimulates calcium-dependent glutamate release from cultured astrocytes. J Neurochem 2001; 77 (2): 664-75 (Pubitemid 32298761)
68. Bezzi P, DomercqM, Brambilla L, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4 (7): 702-10 (Pubitemid 32595408)
69. Takano T, Kang J, Jaiswal JK, et al. Receptor-mediated glutamate release from volume sensitive channels in astrocytes. Proc Natl Acad Sci USA 2005; 102 (45): 16466-71 (Pubitemid 41688937)
70. Kang N, Xu J, Xu Q, et al. Astrocytic glutamate releaseinduced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J Neurophysiol 2005; 94 (6): 4121-30 (Pubitemid 41691773)
71. Domercq M, Brambilla L, Pilati E, et al. P2Y1 receptorevoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins. J Biol Chem 2006; 281 (41): 30684-96 (Pubitemid 44582124)
72. Bowser DN, Khakh BS. Two forms of single-vesicle astrocyte exocytosis imaged with total internal reflection fluorescence microscopy. Proc Natl Acad Sci USA 2007; 104 (10): 4212-7 (Pubitemid 47181604)
73. Calì C, Marchaland J, Regazzi R, et al. SDF 1-alpha (CXCL12) triggers glutamate exocytosis from astrocytes on a millisecond time scale: imaging analysis at the singlevesicle level with TIRF microscopy. J Neuroimmunol 2008; 198 (1-2): 82-91
74. Montana V, Ni Y, Sunjara V, et al. Vesicular glutamate transporter-dependent glutamate release from astrocytes. J Neurosci 2004; 24 (11): 2633-42 (Pubitemid 38380939)
75. Bezzi P, Gundersen V, Galbete JL, et al. Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 2004; 7 (6): 613-20 (Pubitemid 38691900)
76. Martineau M, Galli T, Baux G, et al. Confocal imaging and tracking of the exocytotic routes for D-serine-mediated gliotransmission. Glia 2008; 56 (12): 1271-84
77. Crippa D, Schenk U, Francolini M, et al. Synaptobrevin2-expressing vesicles in rat astrocytes: insights into molecular characterization, dynamics and exocytosis. J Physiol 2006; 570 (Pt 3): 567-82
78. Marchaland J, Calì C, Voglmaier SM, et al. Fast subplasma membrane Ca2+ transients control exoendocytosis of synaptic-like microvesicles in astrocytes. J Neurosci 2008; 28 (37): 9122-32
79. Kreft M, Stenovec M, Rupnik M, et al. Properties of Ca(2+)-dependent exocytosis in cultured astrocytes. Glia 2004; 46 (4): 437-45 (Pubitemid 38679201)
80. Zhang Q, Pangrsici T, Kreft M, et al. Fusion-related release of glutamate from astrocytes. J Biol Chem 2004; 279 (13): 12724-33 (Pubitemid 38445844)
81. Chen X, Wang L, Zhou Y, et al. 'Kiss-and-run' glutamate secretion in cultured and freshly isolated rat hippocampal astrocytes. J Neurosci 2005; 25 (40): 9236-43 (Pubitemid 41500832)
82. Zhang Q, Fukuda M, Van Bockstaele E, et al. Synaptotagmin IV regulates glial glutamate release. Proc Natl Acad Sci USA 2004; 101 (25): 9441-6 (Pubitemid 38812893)
83. Bergersen LH, Gundersen V. Morphological evidence for vesicular glutamate release from astrocytes. Neuroscience 2009; 158 (1): 260-5
84. Kasai H. Comparative biology of Ca2+-dependent exocytosis: implications of kinetic diversity for secretory function. Trends Neurosci 1999; 22 (2): 88-93 (Pubitemid 29125556)
85. Santello M, Volterra A. Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience 2009; 158 (1): 253-9
86. Perea G, Araque A. Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J Neurosci 2005; 25 (9): 2192-203 (Pubitemid 40322260)
87. D'Ascenzo M, Fellin T, Terunuma M, et al. mGluR5 stimulates gliotransmission in the nucleus accumbens. Proc Natl Acad Sci USA 2007; 104 (6): 1995-2000 (Pubitemid 46239892)
88. Agulhon C, Petravicz J, McMullen AB, et al. What is the role of astrocyte calcium in neurophysiology? Neuron 2008; 59 (6): 932-46
89. Smith K. Neuroscience: settling the great glia debate. Nature 2010; 468 (7321): 160-2
90. Chuquet J, Hollender L, Nimchinsky EA. High-resolution in vivo imaging of the neurovascular unit during spreading depression. J Neurosci 2007; 27 (15): 4036-44 (Pubitemid 46597148)
91. Peng X, Zhang C, Alkayed NJ, et al. Dependency of cortical functional hyperemia to forepaw stimulation on epoxygenase and nitric oxide synthase activities in rats. J Cereb Blood Flow Metab 2004; 24 (5): 509-17 (Pubitemid 38608282)
92. Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 2000; 29 (1): 1-13 (Pubitemid 30031129)
93. Rossi D, Brambilla L, Valori CF, et al. Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ 2008; 15 (11): 1691-700
94. Rodriguez JJ, Olabarria M, Chvatal A, et al. Astroglia in dementia and Alzheimer's disease. Cell DeathDiffer 2009; 16 (3): 378-85
95. Hewett JA. Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J Neurochem 2009; 110 (6): 1717-36
96. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007; 28 (3): 138-45 (Pubitemid 46283692)
97. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci 2009; 32 (12): 638-47
98. Perry VH, Bell MD, Brown HC, et al. Inflammation in the nervous system. Curr Opin Neurobiol 1995; 5 (5): 636-41
99. Rossi D, Brambilla L, Valori CF, et al. Defective tumor necrosis factor-alpha-dependent control of astrocyte glutamate release in a transgenic mouse model of Alzheimer disease. J Biol Chem 2005; 280 (51): 42088-96 (Pubitemid 43023177)
100. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 1993; 43 (11): 2245-52 (Pubitemid 23346956)
101. Budka H, Costanzi G, Cristina S, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV): a histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987; 75 (2): 185-98 (Pubitemid 18011902)
102. Eilbott DJ, Peress N, Burger H, et al. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc Natl Acad Sci USA 1989; 86 (9): 3337-41 (Pubitemid 19129606)
103. Petito CK, Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol 1995; 146 (5): 1121-30
104. Magnuson DS, Knudsen BE, Geiger JD, et al. Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995; 37 (3): 373-80
105. Kaul M, Zheng J, Okamoto S, et al. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 2005; 12 Suppl. 1: 878-92 (Pubitemid 41038393)
106. Mattson MP, Haughey NJ, Nath A. Cell death in HIV dementia. Cell Death Differ 2005; 12 Suppl. 1: 893-904 (Pubitemid 41030604)
107. Meucci O, Miller RJ. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TGF-beta1. J Neurosci 1996; 16 (13): 4080-8 (Pubitemid 26192404)
108. Toggas SM, Masliah E, Mucke L. Prevention of HIV-1 gp120-induced neuronal damage in the central nervous system of transgenic mice by the NMDA receptor antagonist memantine. Brain Res 1996; 706 (2): 303-7 (Pubitemid 26046728)
109. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410 (6831): 988-94 (Pubitemid 32335850)
110. Schifitto G, Navia BA, Yiannoutsos CT, et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 2007; 21 (14): 1877-86 (Pubitemid 47329764)
111. Zhao Y,Navia BA, Marra CM, et al. Memantine for AIDS dementia complex: open-label report of ACTG 301. HIV Clin Trials 2010; 11 (1): 59-67
112. Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. NatRev Drug Discov 2006; 5 (2): 160-70
113. Lipton SA. Pathologically-activated therapeutics for neuroprotection: mechanism ofNMDAreceptor block by memantine and S-nitrosylation. Curr Drug Targets 2007; 8 (5): 621-32 (Pubitemid 46785060)
114. Pearse DD, Pereira FC, Stolyarova A, et al. Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages. Eur J Neurosci 2004; 20 (12): 3387-96 (Pubitemid 40013548)
115. Van Eldik LJ, Thompson WL, Ralay Ranaivo H, et al. Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches. Int Rev Neurobiol 2007; 82: 277-96
116. Janelsins MC, Mastrangelo MA, Oddo S, et al. Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer's disease mice. J Neuroinflammation 2005; 2: 23
117. Kaushal V, Schlichter LC. Mechanisms of microgliamediated neurotoxicity in a new model of the stroke penumbra. J Neurosci 2008; 28 (9): 2221-30 (Pubitemid 351317617)
118. Marchand F, Tsantoulas C, Singh D, et al. Effects of etanercept and minocycline in a rat model of spinal cord injury. Eur J Pain 2009; 13 (7): 673-81
119. Tobinick E. Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence. CNS Drugs 2009; 23 (9): 713-25
120. Chio CC, Lin JW, Chang MW, et al. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem 2010; 115 (4): 921-9
121. Clark IA, Alleva LM, Vissel B. The roles of TNF in brain dysfunction and disease. Pharmacol Ther 2010; 128 (3): 519-48
122. Shen CH, Tsai RY, Shih MS, et al. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth Analg 2010; 112 (2): 454-9
123. Lim GP, Yang F, Chu T, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 2000; 20 (15): 5709-14 (Pubitemid 30636898)
124. Jantzen PT, Connor KE, DiCarlo G, et al. Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice. J Neurosci 2002; 22 (6): 2246-54 (Pubitemid 35386524)
125. Choi JK, Jenkins BG, Carreras I, et al. Anti-inflammatory treatment in AD mice protects against neuronal pathology. Exp Neurol 2010; 223 (2): 377-84
126. Martin BK, Szekely C, Brandt J, et al. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol 2008; 65 (7): 896-905 (Pubitemid 352008472)
127. Vlad SC,Miller DR, KowallNW, et al. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 2008; 70 (19): 1672-7 (Pubitemid 351644133)
128. Abraham NS, El-Serag HB, Hartman C, et al. Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther 2007; 25 (8): 913-24 (Pubitemid 46525353)
129. Andersohn F, Schade R, Suissa S, et al. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke 2006; 37 (7): 1725-30 (Pubitemid 44297720)
130. Chen LC, Ashcroft DM. Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A metaanalysis of randomized controlled trials. J Clin Pharm Ther 2006; 31 (6): 565-76 (Pubitemid 44813768)
131. Andreasson K. Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 2010; 91 (3-4): 104-12
132. Ahmad AS, Saleem S, Ahmad M, et al. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol Sci 2006; 89 (1): 265-70 (Pubitemid 43013774)
133. Kawano T, Anrather J, Zhou P, et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat Med 2006; 12 (2): 225-9 (Pubitemid 43214750)
134. Abe T, Kunz A, Shimamura M, et al. The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J Cereb Blood Flow Metab 2009; 29 (1): 66-72
135. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120 (3): 885-90 (Pubitemid 14104991)
136. Cummings BJ, Pike CJ, Shankle R, et al. Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol Aging 1996; 17 (6): 921-33 (Pubitemid 27022746)
137. Naslund J, Haroutunian V, Mohs R, et al. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 2000; 283 (12): 1571-7 (Pubitemid 30161512)
138. Bussiere T, Friend PD, Sadeghi N, et al. Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 2002; 112 (1): 75-91 (Pubitemid 34603499)
139. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298 (5594): 789-91 (Pubitemid 35231524)
140. LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002; 3 (11): 862-72
141. Busche MA, Eichhoff G, Adelsberger H, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008; 321 (5896): 1686-9
142. Kuchibhotla KV, Lattarulo CR, Hyman BT, et al. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009; 323 (5918): 1211-5
143. Takano T, Han X, Deane R, et al. Two-photon imaging of astrocytic Ca2+ signalling and the microvasculature in experimental mice models of Alzheimer's disease. Ann N Y Acad Sci 2007; 1097: 40-50 (Pubitemid 47084881)
144. Abramov AY, Canevari L, Duchen MR. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J Neurosci 2003; 23 (12): 5088-95 (Pubitemid 36793236)
145. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? NatMed 2006; 12 (9): 1005-15 (Pubitemid 44353380)
146. McGeer PL, McGeer EG. Local neuroinflammation and the progression of Alzheimer's disease. J Neurovirol 2002; 8 (6): 529-38 (Pubitemid 36104718)
147. Ralay Ranaivo H, Craft JM, Hu W, et al. Glia as a therapeutic target: selective suppression of human amyloidbeta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J Neurosci 2006; 26 (2): 662-70 (Pubitemid 43237131)
148. Giuliani F, Vernay A, Leuba G, et al. Decreased behavioral impairments in an Alzheimer mice model by interfering with TNF-alpha metabolism. Brain Res Bull 2009; 80 (4-5): 302-8
149. Zhao M, Cribbs DH, Anderson AJ, et al. The induction of the TNFalpha death domain signalling pathway in Alzheimer's disease brain. Neurochem Res 2003; 28 (2): 307-18 (Pubitemid 36207354)
150. Del Villar K, Miller CA. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA 2004; 101 (12): 4210-5 (Pubitemid 38405908)
151. Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNFalpha. Science 2002; 295 (5563): 2282-5 (Pubitemid 34258846)
152. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-alpha. Nature 2006; 440 (7087): 1054-9
153. Kaneko M, Stellwagen D, Malenka RC, et al. Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron 2008; 58 (5): 673-80 (Pubitemid 351778470)
154. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79 (4): 1431-568 (Pubitemid 29473320)
155. Nedergaard M. Neuronal injury in the infarct border: a neuropathological study in the rat. Acta Neuropathol 1987; 73 (3): 267-74 (Pubitemid 17077886)
156. Nedergaard M, Astrup J, Klinken L. Cell density and cortex thickness in the border zone surrounding old infarcts in the human brain. Stroke 1984; 15 (6): 1033-9 (Pubitemid 15175245)
157. Rossi DJ, Brady JD, Mohr C. Astrocyte metabolism and signalling during brain ischemia. Nat Neurosci 2007; 10 (11): 1377-86 (Pubitemid 350014689)
158. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13: 171-82 (Pubitemid 20100647)
159. Hansen AJ, Nedergaard M. Brain ion homeostasis in cerebral ischemia. Neurochem Pathol 1988; 9: 195-209 (Pubitemid 19164804)
160. Silver IA, Deas J, Erecinska M. Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience 1997; 78 (2): 589-601 (Pubitemid 27170347)
161. Mies G, Kohno K, Hossmann KA. Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat. J Cereb Blood Flow Metab 1994; 14 (5): 802-7 (Pubitemid 24266531)
162. Phillis JW, Smith-Barbour M, O'Regan MH. Changes in extracellular amino acid neurotransmitters and purines during and following ischemias of different durations in the rat cerebral cortex. Neurochem Int 1996; 29 (2): 115-20 (Pubitemid 26231997)
163. Higuchi T, Takeda Y, Hashimoto M, et al. Dynamic changes in cortical NADH fluorescence and direct current potential in rat focal ischemia: relationship between propagation of recurrent depolarization and growth of the ischemic core. J Cereb Blood Flow Metab 2002; 22 (1): 71-9 (Pubitemid 34038385)
164. XieM,WangW, Kimelberg HK, et al. Oxygen and glucose deprivation-induced changes in astrocyte membrane potential and their underlying mechanisms in acute rat hippocampal slices. J Cereb Blood Flow Metab 2008; 28 (3): 456-67 (Pubitemid 351304259)
165. Duffy S, MacVicar BA. In vitro ischemia promotes calcium influx and intracellular calcium release in hippocampal astrocytes. J Neurosci 1996; 16 (1): 71-81 (Pubitemid 26010700)
166. Budd SL, Lipton SA. Calcium tsunamis: do astrocytes transmit cell death messages via gap junctions during ischemia? Nat Neurosci 1998; 1 (6): 431-2
167. Nedergaard M, Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005; 50 (4): 281-6 (Pubitemid 40780834)
168. Ding S, Wang T, Cui W, et al. Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signalling in vivo. Glia 2009; 57 (7): 767-76
169. Juranyi Z, Sperlagh B, Vizi ES. Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 1999; 823 (1-2): 183-90 (Pubitemid 29225507)
170. Melani A, Turchi D, Vannucchi MG, et al. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 2005; 47 (6): 442-8 (Pubitemid 41242625)
171. Fellin T, Pozzan T, Carmignoto G. Purinergic receptors mediate two distinct glutamate release pathways in hippocampal astrocytes. J Biol Chem 2006; 281 (7): 4274-84 (Pubitemid 43847857)
172. Oliveira JF, Riedel T, Leichsenring A, et al. Rodent cortical astroglia express in situ functional P2X7 receptors sensing pathologically high ATP concentrations. Cereb Cortex 2010; 21 (4): 806-20
173. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16 (3): 675-86 (Pubitemid 26103145)
174. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005; 50 (4): 307-20 (Pubitemid 40780837)
175. Kimelberg HK. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005; 50 (4): 389-97 (Pubitemid 40780842)
176. Dawson DA, Wadsworth G, Palmer AM. A comparative assessment of the efficacy and side-effect liability of neuroprotective compounds in experimental stroke. Brain Res 2001; 892 (2): 344-50 (Pubitemid 32141221)
177. Devuyst G, Bogousslavsky J. Update on recent progress in drug treatment for acute ischemic stroke. J Neurol 2001; 248 (9): 735-42 (Pubitemid 32802106)
178. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002; 67 (2): 161-72 (Pubitemid 34786168)
179. Barone FC, Arvin B, White RF, et al. Tumor necrosis factor-alpha: a mediator of focal ischemic brain injury. Stroke 1997; 28 (6): 1233-44 (Pubitemid 27248902)
180. Tobinick E. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs 2011; 25 (2): 145-55
181. Candelario-Jalil E, Gonzá lez-Falcón A,García- Cabrera M, et al. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat. Brain Res 2004; 1007 (1-2): 98-108 (Pubitemid 38520177)
182. Candelario-Jalil E, Gonzá lez-Falcón A,García- Cabrera M, et al. Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats. JNeurochem 2007; 100 (4): 1108-20 (Pubitemid 46213933)
183. Nakayama M, Uchimura K, ZhuRL, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998; 95 (18): 10954-9 (Pubitemid 28413175)
184. Yamazaki K, Endo T, Kitajima Y, et al. Elevation of both cyclooxygenase-2 and prostaglandin E2 receptor EP3 expressions in rat placenta after uterine artery ischemiareperfusion. Placenta 2006; 27 (4-5): 395-401
185. Ahmad M, Ahmad AS, Zhuang H, et al. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury. J Neuroimmunol 2007; 184 (1-2): 172-9 (Pubitemid 46365999)
186. Ahmad AS, Yun YT, Ahmad M, et al. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation. Neurotox Res 2008; 14 (4): 343-51
187. Liu D, Wu L, Breyer R, et al. Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia. Ann Neurol 2005; 57 (5): 758-61 (Pubitemid 40628868)
188. McCullough L, Wu L, Haughey N, et al. Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 2004; 24 (1): 257-68 (Pubitemid 38181690)
189. Ahmad AS, Ahmad M, de Brum-Fernandes AJ, et al. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity. Brain Res 2005; 1066 (1-2): 71-7 (Pubitemid 41790730)
190. Li J, Liang X, Wang Q, et al. Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia. Neurosci Lett 2008; 438 (2): 210-5
191. Tian GF, Azmi H, Takano T, et al. An astrocytic basis of epilepsy. Nat Med 2005; 11 (9): 973-81 (Pubitemid 41294443)
192. Fellin T, Gomez-Gonzalo M, Gobbo S, et al. Astrocytic glutamate is not necessary for the generation of epileptiform neuronal activity in hippocampal slices. J Neurosci 2006; 26 (36): 9312-22 (Pubitemid 44359857)
193. Ding S, Fellin T, Zhu Y, et al. Enhanced astrocytic Ca2+ signals contribute to neuronal excitotoxicity after status epilepticus. J Neurosci 2007; 27 (40): 10674-84 (Pubitemid 47535867)
194. Gomez-Gonzalo M, Losi G, Chiavegato A, et al. An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol 2010; 8 (4): e1000352
195. Thrane AS, Rappold PM, Fujita T, et al. Critical role of aquaporin-4 (AQP4) in astrocytic Ca2+ signalling events elicited by cerebral edema. Proc Natl Acad Sci USA 2011; 108 (2): 846-51